California industries are urging federal officials to assess the costs and benefits of a guidance for protecting against cardiac birth defects from exposure to trichloroethylene (TCE), arguing the Environmental Protection Agency policy is based on uncertain science and will cost companies millions of dollars.
December 27, 2025
